3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
3
Phase 4
1
Status
Completed
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other hematologic neoplasm
1
Conditions
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
12
Leukemia
4
Leukemia, Myeloid, Chronic-Phase
2
Gastrointestinal Stromal Tumors
2
Blast Crisis
2
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Piebaldism
1
Philadelphia Chromosome
1
Myeloproliferative Disorders
1
Interventions
nilotinib
1
Idarubicin
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 4
×
Philadelphia Chromosome
×
nilotinib
×
Clear all
NCT01061177
2017-02-24
'MACS1252
Novartis
Phase 4
Completed
1,090 enrolled
24 charts